Duvet Rhinoplasty

Duvet Rhinoplasty is a rhinoplasty technique developed by Dr. Garcia Ceballos to solve a specific problem: the appearance of small visible irregularities on the dorsum of the nose after rhinoplasty, especially in patients with thin nasal skin.

In any rhinoplasty, the surgeon reshapes the bones and cartilage that give shape to the nose. When the skin covering this structure is thin, any slight irregularity of the underlying skeleton may become transparent over time and become visible as a ridge, an asymmetry or a step. This is one of the most frequent reasons for dissatisfaction after a technically well-executed rhinoplasty.

Duvet Rhinoplasty adds to conventional surgery a protective biological layer obtained from the patient himself: a thin, uniform layer of nano-fat (fat processed to microscopic size) enriched with L-PRF, a regenerative substance derived from the patient’s blood. This blanket is placed over the nasal skeleton before the skin is closed, and acts as a cushion that conceals any minor irregularities and improves tissue quality in the long term.

Duvet Rhinoplasty is primarily intended for patients who have thin nasal skin. In these cases, the risk of dorsal irregularities showing after surgery is higher than in patients with thick skin.

The thickness of the skin is measured in the first consultation with a simple instrument called an adipometer, painless, similar to the one used in nutrition to measure skin folds. According to the thickness obtained, the patient is classified into:

• Type I – thin skin (less than 3 millimeters). This is the group that benefits the most from Duvet Rhinoplasty, because it has a higher probability of visible irregularities after a conventional rhinoplasty.
• Type II – thick skin (3 millimeters or more). In this group the risk is lower and conventional rhinoplasty, complemented with techniques to control inflammation and improve definition, is usually sufficient.

It is also a good indication for secondary rhinoplasty: patients who have already undergone surgery on another occasion and whose nasal dorsum presents visible irregularities that need to be corrected.

The clinical results of the technique were published in the 2024 scientific article in Cirugía Plástica Ibero-Latinoamericana. In the series of patients treated between 2022 and 2023:

Beyond the numbers, there are three clinical advantages that the technique brings to the patient:

1. It significantly reduces the risk of visible irregularities of the nasal dorsum after months, which is the most frequent late esthetic problem in thin-skinned patients.
2. Improves the quality and thickness of the nasal skin in the long term, thanks to the regenerative effect of L-PRF and the contribution of microgranules of own fat.
3. It uses the patient’s own materials, without synthetic products or artificial fillers, which minimizes the risk of adverse reactions and guarantees maximum biocompatibility.

Duvet Rhinoplasty does not replace conventional rhinoplasty, it complements it. The same surgical steps are performed – bone and cartilage remodeling, nasal tip adjustment, septum correction if necessary – but an additional step is added at the end: the preparation and application of the biological mantle.

Irregularities of the nasal dorsum in the late postoperative period constitute one of the most frequent aesthetic complications in aesthetic rhinoplasty. Its incidence is particularly high in patients with thin nasal skin envelope (thickness < 3 mm), where the tissue transparency allows the visualization of any irregularity of the underlying bone and cartilage skeleton, either by imperfections of the remodeling, by small natural asymmetries, or by the scar consolidation itself.

The classic techniques to mitigate this problem – careful bone polishing, use of crushed cartilage grafts, application of temporary fascia or perichondrium – offer partially satisfactory results but do not eliminate the incidence. Fascia grafts add donor site morbidity; shredded cartilage may be unevenly resorbed; and none of these techniques improves the quality of the skin envelope itself.

Duvet Rhinoplasty proposes a different approach: instead of adding a solid tissue graft on the back, it provides a bioactive biological mantle (L-PRF-enriched nanofat) that simultaneously fulfills two functions:

1. Mechanical function: distributes skin pressure evenly over the back, optically smoothing the irregularities of the underlying skeleton.
2. Regenerative function: it provides growth factors and adipocyte progenitors that progressively improve the thickness and quality of the skin envelope over the following months.

Component 1: Nanofat

The nanofat is obtained from the patient’s own adipose tissue (typically from the infraumbilical area or flanks) by means of small volume liposuction. The extracted fat is processed by controlled mechanical emulsification until a homogeneous suspension of micrometer size is obtained. This processing removes mature adipocytes but preserves the vascular stromal fraction, rich in adipocyte mesenchymal stem cells, growth factors and extracellular matrix proteins.

Unlike conventional fat grafting, nanofat does not provide significant volume – the adipocyte material is fragmented – but it does provide a regenerative substrate of high biological value, ideal for improving tissue quality in regions where volumetric augmentation is not sought, such as the nasal skin envelope.

Component 2: L-PRF

L-PRF is obtained by centrifugation of the patient’s peripheral blood without the use of anticoagulants, according to the protocol described by Choukroun. The resulting product is a three-dimensional matrix of autologous fibrin that retains in its lattice activated platelets, leukocytes, and a sustained reservoir of growth factors (PDGF, TGF-β, VEGF, IGF-1, EGF) that are progressively released for 7-14 days after application.

Unlike classic PRP, L-PRF does not require anticoagulants or exogenous activators, which makes it an entirely autologous product that is easy to handle intraoperatively. Its gelatinous and malleable consistency facilitates its application as anatomical surface coverage.

Combination: the synergistic effect

The combination of nanofat with L-PRF produces a biological mantle with complementary properties: the nanofat provides the cellular and matrix substrate, while the L-PRF acts as a gel-like vehicle that holds the nanofat in position on the nasal dorsum and releases the growth factors that stimulate graft integration and regeneration of the underlying skin envelope.

The result is a thin, autologous, bioactive mantle that is applied directly to the nasal skeleton prior to skin closure, with progressive resorption and tissue remodeling over the following months.

Preoperative evaluation

Measurement of the thickness of the nasal skin envelope with manual adipometer at the medial osseous dorsum. Classification of the patient according to the criteria described in the classification of rhinoplasty according to soft tissue thickness:

• Type I: < 3 mm – main indication for Duvet Rhinoplasty.
• Type II: ≥ 3 mm – selective indication, according to individual assessment.

Preparation of L-PRF

At the beginning of the surgery, standard venous extraction is performed (typically 4 x 10 mL tubes without anticoagulant) and immediate centrifugation according to protocol (approximately 2700 rpm for 12 minutes in a dedicated centrifuge). L-PRF clots are obtained and processed in a compression box to obtain thin membranes or fragmented according to the intended application.

Obtaining and processing of nanograsses

Small volume liposuction (10-20 mL) in selected donor area, with fine cannula and low suction pressure to preserve the vascular stromal fraction. The extracted fat is decanted, washed with saline, and emulsified by repeated passage (typically 30 passages) between two syringes connected by a luer-lock connector of decreasing diameter, until a homogeneous suspension of characteristic milky appearance is obtained.

Combination and application

The nanofat is mixed with the fragmented L-PRF in a ratio of approximately 1:1, obtaining a manageable matrix that is applied directly on the remodeled nasal dorsum by means of a fine cannula or specific instruments, after completing all the steps of the rhinoplasty and before skin closure.

Associated conventional rhinoplasty

The rhinoplasty procedure itself – open or closed approach, osteotomies, modification of the bony and cartilaginous dorsum, tip adjustment, functional septoplasty if applicable – is performed according to the surgeon’s technical preferences and the specific indications of the case. Duvet Rhinoplasty is compatible with any basic rhinoplasty technique, whether structural, preservation or conservation.

Closure and postoperative period

Standard skin closure and nasal splinting according to standard protocol. The postoperative period does not differ substantially from that of a conventional rhinoplasty, except for a slightly larger volume of the nasal dorsum during the first 2-4 weeks due to the biological mantle, which resolves progressively with the integration of the graft.

Clinical data on the technique were published in Cirugía Plástica Ibero-Latinoamericana, Vol. 50, No. 4, 2024, on a series of patients operated on between 2022 and 2023 with a minimum follow-up of one year.

These data support the hypothesis that the combination of nanofat + L-PRF, applied as a biological mantle on the nasal dorsum in patients with thin skin, effectively prevents the appearance of late visible irregularities and produces measurable improvements of the skin envelope, without adding relevant morbidity to the procedure.

Indications

• Primary rhinoplasty in patient Type I (skin envelope < 3 mm).
• Secondary rhinoplasty with irregular dorsum, residual skin asymmetries or atrophy of the envelope.
• Patients with high aesthetic expectations in whom the quality of the long-term result is to be maximized.
• Selective indication in Type II in cases with marked alterations of the nasal skeleton or when the aesthetic trajectory of the patient justifies it.

Contraindications

• Significant hematologic disorders that contraindicate venous collection or safe handling of the patient’s blood.
• Active anticoagulant treatment not susceptible to perioperative suspension.
• Active infectious processes in the donor area of the nanograss or on the face.
• Insufficient donor adipose tissue (patients with very low body mass index).

Recognized limitations

• The technique adds surgical time (estimated at 30-45 minutes for the preparation of the components).
• It requires the availability of a specific centrifuge for L-PRF and instruments for nanograss processing.
• The immediate postoperative volume of the nasal dorsum is slightly larger than in conventional rhinoplasty, which should be anticipated by the patient.
• The published evidence is from single-surgeon clinical series; prospective multicenter comparative studies would be desirable to strengthen the evidence.